Sanofi says that its experimental drug amlitelimab has the potential to become a ‘best-in-class’ maintenance therapy for atopic dermatitis (AD) after reporting new phase 2b data. The latest results ...

The state is guaranteeing a $2 bln loan to JLR, whose IT systems were attacked. Domestic industries received similar support during Covid-19, but this crisis could have been mitigated with proper ...